These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15065507)

  • 1. [Neuroleptic malignant syndrome--in need of acute care].
    Poutanen O; Kiviniemi P
    Duodecim; 2004; 120(2):163-8. PubMed ID: 15065507
    [No Abstract]   [Full Text] [Related]  

  • 2. Early diagnosis of neuroleptic malignant syndrome.
    Grey P
    J Clin Psychiatry; 1986 Mar; 47(3):154. PubMed ID: 2869029
    [No Abstract]   [Full Text] [Related]  

  • 3. "Atypical" neuroleptic malignant syndrome and the spectrum of malignant cerebrotoxic syndromes.
    Choi-Kain LW; Pope HG
    Harv Rev Psychiatry; 2007; 15(4):181-6. PubMed ID: 17687712
    [No Abstract]   [Full Text] [Related]  

  • 4. [Malignant syndromes due to psychotherapeutic agents].
    Chen YG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Dec; 20(6):332-3. PubMed ID: 2896110
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome related to use of clozapine.
    Trayer JS; Fidler DC
    J Am Osteopath Assoc; 1998 Mar; 98(3):168-9. PubMed ID: 9558834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroleptic malignant syndrome (dopamine-dependent malignant hyperthermia). 4 different cases].
    Truong DD; Sczesni B; Fahn S; Gross J; Donovan K; van Bakel A; Wiley MK
    Nervenarzt; 1988 Feb; 59(2):103-9. PubMed ID: 2896306
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paliperidone-associated atypical neuroleptic malignant syndrome: a case report.
    Han C; Lee SJ; Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):650-1. PubMed ID: 21163319
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome: long-term follow-up of 20 cases.
    Pope HG; Aizley HG; Keck PE; McElroy SL
    J Clin Psychiatry; 1991 May; 52(5):208-12. PubMed ID: 1674508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome caused by combination of risperidone and lithium in a patient with multiple medical comorbidities.
    Kosehasanogullari SG; Akdede B; Akvardar Y; Akan M; Tunca Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1147-8. PubMed ID: 17513032
    [No Abstract]   [Full Text] [Related]  

  • 11. Dantrolene in lethal catatonia.
    Pennati A; Sacchetti E; Calzeroni A
    Am J Psychiatry; 1991 Feb; 148(2):268. PubMed ID: 1670981
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of external heat load in triggering the neuroleptic malignant syndrome.
    Shalev A; Hermesh H; Munitz H
    Am J Psychiatry; 1988 Jan; 145(1):110-1. PubMed ID: 2892428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome.
    Bhattacharyya K
    J Assoc Physicians India; 1999 Sep; 47(9):940. PubMed ID: 10778680
    [No Abstract]   [Full Text] [Related]  

  • 14. Atypical neuroleptic malignant syndrome associated with iloperidone administration.
    Guanci N; Aggarwal R; Schleifer S
    Psychosomatics; 2012; 53(6):603-5. PubMed ID: 23157999
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuroleptic treatment of schizophrenia.
    Lauriello J; Jeste DV
    Compr Ther; 1992 Jan; 18(1):30-5. PubMed ID: 1346590
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome with renal and respiratory complications--a case report.
    Liam CK; Ong SB
    Singapore Med J; 1990 Apr; 31(2):182-4. PubMed ID: 1973548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precautionary measures reduce risk of definite neuroleptic malignant syndrome in newly typical neuroleptic-treated schizophrenia inpatients.
    Shiloh R; Valevski A; Bodinger L; Misgav S; Aizenberg D; Dorfman-Etrog P; Weizman A; Munitz H
    Int Clin Psychopharmacol; 2003 May; 18(3):147-9. PubMed ID: 12702893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium-induced fatal neuroleptic malignant syndrome in a patient not being concomitantly treated with commonly offending agents.
    Argyriou AA; Drakoulogona O; Karanasios P; Kouliasa L; Leonidou L; Giannakopoulou F; Goudas P; Makris N
    J Pain Symptom Manage; 2012 Dec; 44(6):e4-6. PubMed ID: 23217454
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neuroleptic malignant syndrome: a neurologic pathology of great interest for the internist].
    Blasi C; D'Amore F; Levati M; Bandinelli MC
    Ann Ital Med Int; 1998; 13(2):111-6. PubMed ID: 9734143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine usage associated with neuroleptic malignant syndrome.
    Philibert RA; Adam LA; Frank FM; Carney-Doebbeling C
    Psychosomatics; 2001; 42(6):528-9. PubMed ID: 11815691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.